Related Experiment Video
Updated: May 28, 2026
Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
Published on: October 17, 2017
The potential role of RTN3 in monocyte recruitment and atherosclerosis
Yaqin Chen1, Rong Xiang, Shuiping Zhao
1Department of Cardiology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.
Insights
Reticulon 3 (RTN3) may play a role in atherosclerosis development by influencing monocyte adhesion, migration, and transformation into macrophages within the arterial wall. Further research is needed to confirm RTN3
Area of Science:
- Cardiovascular Biology
- Immunology
- Molecular Medicine
Background:
- Atherosclerosis (AS) pathogenesis involves monocyte recruitment and differentiation into macrophages in the arterial wall.
- Reticulon 3 (RTN3), a reticulon family protein, is implicated as a potential pathogenic factor in AS progression.
- The specific roles of RTN3 in the early stages of AS pathogenesis remain largely uncharacterized.
Purpose of the Study:
- To investigate the potential involvement of RTN3 in the continuous process of circulating monocyte recruitment in atherosclerosis.
- To elucidate the specific mechanisms by which RTN3 may regulate monocyte adhesion, migration, and differentiation.
- To explore RTN3's contribution to the conversion of monocytes to macrophages within the arterial subendothelium.
Main Methods:
- Hypothesis-driven research focusing on RTN3's role in monocyte recruitment.
- In vitro or in vivo models to study monocyte-endothelial interactions.
- Analysis of RTN3 expression and function in the context of AS pathogenesis.
Main Results:
- RTN3 is hypothesized to be involved in monocyte spreading and adhesion to the luminal endothelium.
- RTN3 may play a role in facilitating transendothelial migration of monocytes.
- RTN3 might also contribute to the differentiation of monocytes into macrophages in the subendothelial space.
Conclusions:
- RTN3 is proposed as a key regulator in the early stages of atherosclerosis, specifically in monocyte recruitment and differentiation.
- Understanding RTN3's function could reveal novel therapeutic targets for preventing or treating atherosclerosis.
- Further experimental validation is required to confirm the proposed roles of RTN3 in AS pathogenesis.
Abstract:
The recruitment of monocytes to arterial wall and their transformation into macrophages are generally accepted as important early events in the pathogenesis of atherosclerosis (AS). Our research group found Reticulon3 (RTN3), a member of the reticulon family, may be a candidate pathogenic element in the progress of AS. But it is virtually unknown in which process RTN3 may participate in and regulate the pathogenesis of AS. Here, we hypothesis that RTN3 may participate in the continuous process of circulating monocyte recruitment in AS including: (1) monocyte spreading and adhesion to luminal endothelium; (2) transendothelial migration and may also contribute to the conversion of monocyte to macrophage in subendothelium.
